35 related news articles for Interventional Immunology in Early Life Diseases

BioCurate’s Proof of Concept Fund is working to change this trend by providing crucial support to address critical gaps in promising projects, as exemplified by the groundbreaking work on Interleukin-38 (IL-38) led by Professor Claudia Nold from Hudson Institute of Medical Research and Associate Professor Andrew Ellisdon from the Monash Biomedicine Discovery Institute.…  Read more

Any new parent will tell you how overwhelming it can feel to suddenly be caring for a fragile new life. Now imagine that this life came into the world before it was ready – the fragility is magnified and with it the number of unknowns and things that can go wrong.…  Read more

Congratulations to the recipients of the 2024 Hudson Institute Harold Mitchell Fellowships.

The Travel Fellowships are provided by the Harold Mitchell Foundation, giving young scientists much-needed opportunities to travel and expand their research horizons.…  Read more

Hudson Institute Group Heads, Professor Claudia Nold and Associate Professor Flora Wong were each awarded grants of more than $2 million over the next five years, enabling them to commit long-term to these exciting research projects.…  Read more

Through their grief one young couple has joined Hudson Institute researchers in a bold effort to find out more about the disease that killed their first child, and to end necrotising enterocolitis.…  Read more

When baby Blessing was born at just 25 weeks, her parents joined a medical trial they hope will benefit all preterm babies.…  Read more

The medical research equivalent of vertical integration is rare – which is why Hudson Institute is fortunate to have husband and-wife team Professors Claudia and Marcel Nold, who are engaged in a hugely beneficial working partnership.…  Read more

Congratulations to the recipients of the 2023 Harold Mitchell Travel Fellowships, provided by the Harold Mitchell Foundation to give young scientists much-needed opportunities for to expand their horizons.…  Read more

Shining a light on how the lung microbiome in the first days of life can affect the immune system for years to come, Hudson Institute researchers have taken an important first step in an increasingly relevant field of medical study.…  Read more

When baby Max arrived – early and in a hurry – no-one realised he would play a vital part in keeping other preterm babies healthy in the future.…  Read more

Medical researchers are a big step closer to understanding the inflammatory responses in pre-term babies that can cause devastating heart and lung conditions including bronchopulmonary dysplasia (BPD) and pulmonary hypertension (PH).…  Read more

It’s the essential physiological response that keeps you alive but can also kill you.…  Read more

Two Hudson Institute researchers have been made Associate Members of Australia’s leading health and medical science advocacy body, the Australian Academy of Health and Medical Sciences (AAHMS).…  Read more

Many human diseases, including autoimmune diseases such as arthritis or inflammatory bowel disease, are characterised by too much inflammation.
There has been a gap in producing new generations of potent anti-inflammatory therapeutics for these anti-inflammatory conditions.…  Read more

During his first two months, little Jack endured several setbacks, including having to be put on a ventilator when seizures prevented his breathing.…  Read more

An anti-inflammatory drug that’s been widely used for decades may prove to be an ideal tool to help doctors prevent cerebral palsy in preterm babies.…  Read more

A paper published in the prestigious journal, Science Immunology, explores the idea that studying bats’ responses to SARS-CoV-2 may provide key insights into how and when to best use existing therapies for COVID-19, and to develop new treatments.…  Read more

Melbourne researchers have published a breakthrough study that will accelerate new treatments for an often-fatal disease affecting premature babies in intensive care, called necrotising enterocolitis (NEC).…  Read more

There is something unusual about the initial—or innate—immune response to COVID-19 compared to usual influenza patterns. …  Read more

Hudson Institute researchers provide new insights into how the IL-37 protein blocks inflammation—emphasising the potential for a novel treatment in the fight against a plethora of inflammatory diseases.…  Read more

Hudson Institute researchers have identified a target for controlling the development of colon cancer that could lead to novel treatment strategies.…  Read more

Hudson Institute is delighted to announce the success of our researchers in the new NHMRC Investigator Grant round.…  Read more

New research into an anti-inflammatory drug for treating lung disease in pre-term babies has shown it also has the potential to prevent the disease’s subsequent complication, pulmonary hypertension (PH), a vascular condition that leads to heart failure and death in 50 per cent of cases.…  Read more

An award from the ARC Centre of Excellence for Advanced Molecular Imaging is helping a PhD student drive the future of Australian science and innovation. Holly Ung, from Professor Marcel Nold and Associate Professor Claudia Nold’s Research Group, is taking part in a 12-week research internship in Germany at the Fraunhofer Institute for Cell Therapy…  Read more

Hudson Institute’s finest medical researchers will continue to push the boundaries in their field thanks to continued generous support from Mr Peter Fielding and the Fielding Foundation. This year, Research Group Heads, Associate Professor Claudia Nold (2019 Fielding Foundation Fellowship) and Dr Michael Gantier (2019 Fielding Innovation Award), were rewarded for their innovative scientific projects.…  Read more

Hudson Institute has had outstanding success in the recent NHMRC Project Grant round. In addition, our researchers have been awarded an NHMRC Partnership Grant, an NHMRC Development Grant, an ARC Discovery Grant and three NMHRC Fellowships.…  Read more

Claudia Nold, has received an academic promotion to Associate Professor from Monash University.…  Read more

Hudson Institute researchers have discovered a potential safe and effective treatment for bronchopulmonary dysplasia (BPD), which could save preterm babies from the severe lifelong effects of this incurable premature lung disease.…  Read more

The Fielding Foundation Fellowship 2017 has been jointly awarded to two outstanding immunology researchers at Hudson Institute, Dr Niamh Mangan, from the Centre for Innate Immunity and Infectious Diseases, and Associate Professor Marcel Nold, from The Ritchie Centre.…  Read more

Hudson Institute of Medical Research and Monash University have announced a new research collaboration with the Swiss-based healthcare company Roche (F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.) The collaboration aims to develop next generation treatments for autoimmune diseases, focused on proteins targeting novel molecular pathways.…  Read more

Scientists from across the world discussing immunology research…  Read more

Hudson Institute’s Dr Claudia Nold will use a competitive Heart Foundation Fellowship and Innovation Award to help develop new treatments for cardiopulmonary diseases in preterm babies.…  Read more

Associate Professor Marcel Nold has been named the inaugural winner of the $50,000 Fielding Innovation Award for his work on cytokines, their signalling and role in suppressing inflammation.…  Read more

Hudson Institute’s Dr Claudia Nold has been awarded a prestigious Paul Korner Innovation Award from the Heart Foundation for her research into dangerous diseases associated with premature birth.…  Read more

Scientists who have discovered the mechanism of a protein that suppresses inflammation in the body, say the information could potentially be used to develop new drugs to control inflammation.…  Read more